Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) Short Interest Update

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 31,081 shares, a growth of 302.9% from the August 15th total of 7,714 shares. Based on an average daily volume of 832 shares, the short-interest ratio is presently 37.4 days.

Wall Street Analyst Weigh In

Separately, Citigroup raised Fisher & Paykel Healthcare to a “buy” rating in a report on Thursday. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, Fisher & Paykel Healthcare has a consensus rating of “Moderate Buy”.

Fisher & Paykel Healthcare Price Performance

Fisher & Paykel Healthcare stock remained flat at $25.79 during mid-day trading on Friday. 16,565 shares of the company’s stock were exchanged, compared to its average volume of 3,536. The firm’s fifty day moving average is $24.13 and its 200 day moving average is $23.06. Fisher & Paykel Healthcare has a 1 year low of $19.01 and a 1 year high of $26.53.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.

The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation.